Expand Document  |  Expand Chapter  |  Full TOC  |  Printable HTML version
Comparative Analysis of National Drug Policies - Second Workshop Geneva, 10-13 June 1996 - EDM Research Series No. 025
(1997; 175 pages) View the PDF document
Table of Contents
View the documentExecutive summary
View the documentI. Introduction
Open this folder and view contentsII. Background on the research project
Open this folder and view contentsIII. Second workshop
Open this folder and view contentsIV. Preliminary findings
Open this folder and view contentsV. Conclusions of the workshop and follow-up plans
Open this folder and view contentsAnnex 1: Research proposal
View the documentAnnex 2: List of participants
View the documentAnnex 3: Agenda
View the documentAnnex 4: Questionnaire on NDP performance assessment
Open this folder and view contentsAnnex 5: Achievements of the national drug policies in the 12 countries
View the documentAnnex 6: Consolidated tables
View the documentOther documents in the DAP Research Series

Annex 3: Agenda

Second workshop on the research on the comparative analysis of NDP

Action Programme on Essential Drugs
World Health Organization
Room M-505

Day 1, Monday, 10 June 1996

Session I: Introduction


Introductory remarks by Dr Fernando S. Antezana, ADG

Opening of the workshop by Dr Jonathan D. Quick, Director, DAP
Introduction of participants
Introduction to the workshop by Mrs Pascale Brudon, DAP

Session II: NDP Performance assessment (indicators)

Presentation by countries (15 minutes each)
Presentation by countries (15 minutes each)

Identification and discussion of key methodological problems

Day 2, Tuesday, 11 June 1996

Discussion and resolution of key methodological problems

Analysis and interpretation of the findings

Synthesis of Session II

Day 3, Wednesday, 12 June 1996

Session III: Political mapping

Presentation by countries

Discussion on similarities and differences

Plenary and synthesis of Day 3

Day 4, Thursday, 13 June 1996

Session IV:

Cross national comparison:

• relevance of the systematic cross national method which has been used in the research for assessing NDP;

• review of the hypothesis developed to explain how different strategies affect the outcomes of the policy;

• review of the explanations developed for cross national variations in NDP performance.

• formulation of national and international strategies and specific policy innovations to improve implementation of national drug policies.

Planning next steps

• time schedule for the preparation of the final reports, including methodological refinements;

• strategies for dissemination of the results, including national and international seminars and publications;

• collaboration with policy-makers and donor organizations;

• funding issues. etc.

Closing remarks


to previous section
to next section
The WHO Essential Medicines and Health Products Information Portal was designed and is maintained by Human Info NGO. Last updated: December 6, 2017